conid:1879
-kaloNeDinamik-------------------------------------------jo
-session-------------------------------------------Array
(
    [ID_S] => IP: 3.225.221.130; DATE: 2022/12/09/ 17:00:01
    [tip] => 2
    [contentType] => db
    [ses_userid] => 2
    [thisMode] => 
    [level_0] => 2
    [level_1] => 15
    [level_2] => 3
    [level_3] => 0
    [level_4] => 0
    [level] => 2
    [nodetype] => 2
    [node_family_id] => 0
    [monitor] => content
    [id_contentit_from_php_file] => 1879
    [uniqueid] => 202212091700013225221130743
    [lang] => Lng2
    [contentId] => 1879
    [browser] => IE
    [clas_css] => 0
    [level_p] => 2
    [lng] => Lng2
    [nodetype_ci] => -1
    [usr] => 0
    [vazhdopunen] => po
    [search_for] => ("urogenital neoplasms"[Majr] OR (("neoplasm"[ti] OR neoplasms[ti] OR cancer[ti] OR carcinoma[ti] OR tumor[ti] OR tumour[ti] OR "secondary"[subheading:majr]) AND (bladder[ti] OR prostatic[ti] OR prostate[ti] OR testicular[ti] OR testis[ti] OR penile[ti] OR kidney[ti] OR renal[ti]))  AND ("practice guideline" OR systematic[sb] OR "clinical trials"[mesh] OR "meta analysis"[pt] OR "epidemiologic studies"[mesh] OR randomi* OR "meta analysis" OR "evidence based" OR placebo* OR "single blind" OR "double blind" OR "control group" OR "triple blind" OR study[ti] OR studies[ti] OR trial[ti] OR trials[ti] OR consensus OR placebo OR review[pt] OR "sensitivity and specificity"[MeSH Terms] OR diagnos*[Ti] OR diagnosis[MeSH:noexp] OR diagnostic *[MeSH:noexp] OR diagnosis,differential[MeSH:noexp] OR diagnosis[Subheading:noexp] OR accuracy[Title/Abstract] OR "predictive value"[Title/Abstract]) AND (english[language] OR german[language] OR french[language] OR italian[language] OR spanish[language]) NOT (veterinary[subheading] OR "genital neoplasms, female"[mesh])
)

medline.ch

En | De

Impressum | Feedback

No articles selected!

View Cart

You are here: Oncology » Urologic Neoplasms

09. December 2022

Cardiovascular Diseases

Musculoskeletal Diseases

Neurology

Oncology

Musculoskeletal System

Blood

Endocrine System

Gynecologic Neoplasms

Zoom:

Page 1 of 7505


	Articles 1 - 20 / 150100

	Low-Dose Hemibody Radiation, a Treatment Option for Recurrent Prostate Cancer: A Phase 2 Single-Arm Trial. Adv Radiat Oncol Dayes IS, Kennedy AE, Parpia S, Thome C, Tharmalingam S, Lemon JA, Bowdish DME, Boreham DR. PMID: 36483063 [PubMed - as supplied by publisher]
	Role of hydrogel spacer to protect the rectum from thermal injury in focal therapy of prostate cancer: Preclinical study in cadaver model. Int J Urol Narukawa T, Fujihara A, Ochiai A, Okihara K, Hongo F, Ukimura O. PMID: 36482782 [PubMed - as supplied by publisher]
	Sequential intravesical gemcitabine and docetaxel therapy in patients with nonmuscle invasive bladder cancer: a systematic review and meta-analysis. Curr Opin Urol Kawada T, Yanagisawa T, Araki M, Pradere B, Shariat SF. PMID: 36482766 [PubMed - as supplied by publisher]
	"Stromal cells in prostate cancer pathobiology: friends or foes?". Br J Cancer Pederzoli F, Raffo M, Pakula H, Ravera F, Nuzzo PV, Loda M. PMID: 36482187 [PubMed - as supplied by publisher]
	Automatic diagnosis and grading of Prostate Cancer with weakly supervised learning on whole slide images. Comput Biol Med Xiang J, Wang X, Wang X, Zhang J, Yang S, Yang W, Han X, Liu Y. PMID: 36481762 [PubMed - as supplied by publisher]
	Oncologic outcomes of neoadjuvant chemotherapy in patients with micropapillary variant urothelial carcinoma of the bladder. Urol Oncol Rahman SN, Lokeshwar SD, Syed JS, Javier-Desloges JF, Press BH, Choksi AU, Rajwa P, Pradere B, Ploussard G, Kim JW, Monaghan TF, Renzulli JR, Shariat SF, Leapman MS. PMID: 36481253 [PubMed - as supplied by publisher]
	Effect of Re-TUR time on recurrence and progression in high-risk non-muscle-invasive bladder cancer. Cir Cir Demir DO, Doluoglu OG, Yildiz AK, Kacan T, Yazar VM, Demirbas A, Ozgur BC. PMID: 36480752 [PubMed - as supplied by publisher]
	The prognosis of lipid reprogramming with the HMG-CoA reductase inhibitor, rosuvastatin, in castrated Egyptian prostate cancer patients: Randomized trial. PLoS One Karkeet RM, Zekri AN, Sayed-Ahmed MM, Sherif GM, Salem SE, Abdelbary A, Fouad MA, Saad SY. PMID: 36480560 [PubMed - as supplied by publisher]
	The Experiences and Unmet Supportive Care Needs of Partners of Men Diagnosed With Prostate Cancer: A Meta-aggregation Systematic Review. Cancer Nurs Roberts C, Toohey K, Paterson C. PMID: 36480350 [PubMed - as supplied by publisher]
	Unamplified and Real-Time Label-Free miRNA-21 Detection Using Solution-Gated Graphene Transistors in Prostate Cancer Diagnosis. Adv Sci (Weinh) Deng M, Ren Z, Zhang H, Li Z, Xue C, Wang J, Zhang D, Yang H, Wang X, Li J. PMID: 36480308 [PubMed - as supplied by publisher]
	Preoperative systemic immune-inflammation index as a significant prognostic factor after TURBT in patients with non-muscle-invasive bladder cancer: A retrospective study based on propensity score matching analysis. Cancer Med Ding L, Wang X, Deng X, Xia W, Wang K, Yu X, Huang Y, Wang J. PMID: 36479836 [PubMed - as supplied by publisher]
	Prognostic nomogram based on the lymph node metastasis indicators for patients with bladder cancer: A SEER population-based study and external validation. Cancer Med Li S, Wang Y, Hu X. PMID: 36479835 [PubMed - as supplied by publisher]
	Oncologic Impact of Cystoscopic Findings in Non-Muscle Invasive Bladder Cancer: A Meta-analysis. BJU Int Yanagisawa T, Quhal F, Kawada T, Mostafaei H, Sari Motlagh R, Laukhtina E, Rajwa P, von Deimling M, Bianchi A, Pallauf M, Majdoub M, Pradere B, Abufaraj M, Moschini M, Karakiewicz PI, Iwatani K, Miki J, Kimura T, Shariat SF. PMID: 36479820 [PubMed - as supplied by publisher]
	Optimization of first-line systemic therapy in patients with advanced clear cell renal cell carcinoma. Int J Urol Takagi T. PMID: 36479730 [PubMed - as supplied by publisher]
	Identification of a claudin-low subtype in clear cell renal cell carcinoma with implications for the evaluation of clinical outcomes and treatment efficacy. Front Immunol Zhang C, Li Y, Qian J, Zhu Z, Huang C, He Z, Zhou L, Gong Y. PMID: 36479115 [PubMed - as supplied by publisher]
	The prognosis of bladder cancer is affected by fatty acid metabolism, inflammation, and hypoxia. Front Oncol Xiao Y, Yang J, Yang M, Len J, Yu Y. PMID: 36479065 [PubMed - as supplied by publisher]
	The alternative renin-angiotensin-system (RAS) signalling pathway in prostate cancer and its link to the current COVID-19 pandemic. Mol Biol Rep Sehn F, Büttner H, Godau B, Müller M, Sarcan S, Offermann A, Perner S, Kramer MW, Merseburger AS, Roesch MC. PMID: 36478297 [PubMed - as supplied by publisher]
	Radiotherapy for ductal carcinoma of the prostate: an analysis based on the Japanese radiation oncology study group survey. Jpn J Clin Oncol Kawamura H, Nakamura K, Yoshioka Y, Itasaka S, Tomita N, Onishi M, Iwata H, Aizawa T, Kikuchi K, Nagata K, Nakamura K, Nishioka K, Ishiyama H, Ueno S, Kokubo M, Yamazaki H, Watanabe K, Toyoda T, Akimoto T, JROSG Working Subgroup of Urologic Oncology. PMID: 36478251 [PubMed - as supplied by publisher]
	Novel cryotherapy in non-muscle-invasive bladder cancer. Cancer Ho MD, Modi PK. PMID: 36477685 [PubMed - as supplied by publisher]
	Role of the elastography strain ratio using transrectal ultrasonography in the diagnosis of prostate cancer and clinically significant prostate cancer. Sci Rep Yoo JW, Koo KC, Chung BH, Lee KS. PMID: 36477667 [PubMed - as supplied by publisher]

Articles 1 - 20 / 150100

Page 1 of 7505



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy